Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial.

Messoud Ashina,Stewart J Tepper,Uwe Reuter,Andrew M Blumenfeld,Susan Hutchinson,Jing Xia,Rosa Miceli,Lawrence Severt,Michelle Finnegan,Joel M Trugman

Headache（2023）

Cited 12|Views12
No score
Abstract
Daily use of oral atogepant 60 mg for preventive treatment of migraine during this 1-year, open-label trial was safe, well tolerated, and efficacious.
More
Translated text
Key words
atogepant,calcitonin gene-related peptide,gepant,migraine,migraine preventive
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined